Sanofi Pasteur Vaccine Development Phase 2

project at a glance

Phase 2 of sanofi pasteur's Vaccine Development project was a four-story, 68,230 square foot building with a lower level, a mechanical access mezzanine, first floor and mechanical penthouse.  Part of the Research-to-Launch Laboratory Phase I project, this building is constructed adjacent to and connected by the Salk Building, research to launch facility and Building 50.  The lower level includes two BSL3 class C cleanroom fermentation suites.

NORTH AMERICA

Turner International

For Services / Specializations
and Additional Key Contacts
See Office Network

*Office includes a Special
Projects Division or Interiors
Group